viernes, 13 de febrero de 2026
Moderna’s president weighs in on FDA’s decision not to review its flu vaccine In interview, Stephen Hoge took questions on the impact on the company and others in industry
https://www.statnews.com/2026/02/12/moderna-stephen-hoge-interview-flu-vaccine/
By Matthew Herper, Adam Feuerstein, Elaine Chen, and Allison DeAngelisFeb. 12, 2026
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario